Press Releases

Date Title and Summary
Toggle Summary Five Leading Academic Hospitals Install the CyberKnife System for Dedicated Radiosurgery
Adoption Demonstrates Continued Demand for Dedicated Whole Body Stereotactic Radiosurgery Systems at World's Most Renowned Cancer Centers SUNNYVALE, Calif., July 25, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today
Toggle Summary Fox Chase Cancer Center Purchases CyberKnife System
Nation's First Cancer Hospital Will Use CyberKnife Radiosurgery to Non-invasively Treat Tumors Throughout the Body SUNNYVALE, Calif., Dec. 1 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Fox Chase Cancer Center in
Toggle Summary French Hospital Network Unicancer Acquires Multiple Accuray Radixact® Systems with the ClearRT™ Helical Fan-Beam kVCT Imaging and Synchrony® Technologies
More than 30 Accuray TomoTherapy® and CyberKnife® Platform Systems Are Currently in Use at Unicancer, the Largest Network of Comprehensive Cancer Centers in Europe SUNNYVALE, Calif. , Sept. 29, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Unicancer has selected
Toggle Summary Froedtert & the Medical College of Wisconsin Cancer Network is First in the World to Treat Cancer Patient Using the Accuray Radixact® System with Synchrony® Motion Tracking and Correction Technology
Advanced Radiation Therapy Delivery System and Intrafraction Motion Synchronization Functionality Enable Precise, Efficient Treatment of a 45-Year-Old Man with Lung Cancer SUNNYVALE, Calif. , Aug. 21, 2019 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that physicians at the
Toggle Summary FUCAM Treats 1,000 Breast Cancer Patients with the TomoTherapy® System
System Dedicated Solely to Breast Cancer Care Provides Excellent Clinical Outcomes SUNNYVALE, Calif. , June 21, 2016 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that the Fundación de Cancer de Mama in México City (FUCAM) has treated 1,000 breast cancer patients with the
Toggle Summary Full Breadth and Depth of Accuray’s Advanced, Personalized Radiation Treatment Capabilities Showcased at ESTRO 31
Conference Presentations Highlighted Benefits of the CyberKnife® System’s Motion Management and the TomoTherapy® System’s Daily Image-Guidance SUNNYVALE, Calif., May 16, 2012 – Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that for the first time in
Toggle Summary GE Healthcare and Accuray Collaborate to Expand Access, Advance the Practice of Precision Radiation Therapy
Collaboration places emphasis on personalized medicine; brings together key precision diagnostic and treatment delivery tools aimed at creating shorter, more comfortable and more effective treatments for patients CHICAGO and SUNNYVALE, Calif. , Oct. 21, 2022 /PRNewswire/ -- GE Healthcare and
Toggle Summary Geisinger becomes first in U.S. to treat cancer patients with Accuray Synchrony® technology on the Radixact® and CyberKnife® S7™ Systems to better target radiation treatments
WILKES-BARRE, Pa. and SUNNYVALE, Calif. , May 3, 2021 /PRNewswire/ --   Geisinger continues to bring advanced cancer care closer to home as it is the first hospital system in the U.S. to offer Accuray Incorporated's (NASDAQ: ARAY) newest Synchrony ®  technology on both the CyberKnife ® S7™  and
Toggle Summary Geisinger Medical Center is First in Pennsylvania to Treat Cancer Patients with Accuray Radixact® System
Leading Health Services Organization Hospital Selected the New Radiation Therapy Device to Expand Its Clinical Capabilities and Provide Treatment Options for a Wider Range of Patients SUNNYVALE, Calif. , Sept. 10, 2019 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that the
Toggle Summary Growing Clinical Evidence the Focus of Accuray's TomoTherapy Asia User Education Symposium
4th Annual User Meeting Highlights Breadth and Depth of Clinical Applications and Increasing Utilization across Asia SUNNYVALE, Calif., Sept. 9, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, showcased new clinical research on its

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.